Showing results (471-480 of 638) with videos related to

Sort By:
Pageof 64
British Journal of Clinical Pharmacology|May 1, 1997
Intra-arterial substance P mediated vasodilatation in the human forearm: pharmacology, reproducibility and tolerabilityD E Newby, D G Sciberras, C M Mendel, et al.
European Journal of Pharmacology|September 2, 2000
Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryl trinitrate-tolerant rat femoral arteriesM R Miller, I L Megson, M J Roseberry, et al.
European Journal of Pharmacology|November 25, 2000
Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryltrinitrate-tolerant rat femoral arteriesM R Miller, M J Roseberry, F A Mazzei, et al.
Journal of Cell Science|February 1, 1994
Replication and transcription sites are colocalized in human cellsA B Hassan, R J Errington, N S White, et al.
Journal of Oral Rehabilitation|March 5, 2002
Use of optical coherence tomography for assessment of dental caries: quantitative procedureB T Amaechi, S M Higham, A G Podoleanu, et al.
Scottish Medical Journal|April 1, 1985
A comparison of atenolol and long-acting trimazosin in mild to moderate essential hypertensionD J Webb, M J Hutcheson, M P Robertson, et al.
Biochemical and Biophysical Research Communications|June 15, 1992
The potassium channel opener BRL 38227 inhibits binding of [125I]-labelled endothelin-1 to rat cardiac membranesC J Waugh, M E Dockrell, W G Haynes, et al.
The Journal of Physiology|February 7, 2001
Changes in the derived central pressure waveform and pulse pressure in response to angiotensin II and noradrenaline in manI B Wilkinson, H MacCallum, P C Hupperetz, et al.
Journal of Cardiovascular Pharmacology|January 1, 1993
Modulators of calcium and potassium channels: their effects on endothelin-1 binding to cardiac membranesW G Haynes, C J Waugh, M E Dockrell, et al.
Pageof 64